This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
What Does Philip Morris's Sale of Vectura Group Mean for its Future?
by Zacks Equity Research
PM sells Vectura Group to Molex Asia Holdings amid criticism of its ownership as it seeks to shift from tobacco to healthcare.
Why Philip Morris (PM) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Are Consumer Staples Stocks Lagging Carriage Services (CSV) This Year?
by Zacks Equity Research
Here is how Carriage Services (CSV) and Philip Morris (PM) have performed compared to their sector so far this year.
Strengthen Portfolio Defense With These Buy Rated Stocks: PPC, PM, OLLI
by Derek Lewis
Stocks in the Zacks Consumer Staples sector carry a defensive nature, as these companies' products have an advantageous ability to generate consistent demand in the face of many economic situations.
Here's Why Philip Morris (PM) is a Strong Growth Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Take the Zacks Approach to Beat the Markets: Philip Morris, IAMGOLD, Solventum in Focus
by Santanu Roy
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Are You Looking for a Top Momentum Pick? Why Philip Morris (PM) is a Great Choice
by Zacks Equity Research
Does Philip Morris (PM) have what it takes to be a top stock pick for momentum investors? Let's find out.
PM Stock Hits 52-Week High: Buying Opportunity or Pricey Gamble?
by Zacks Equity Research
Philip Morris is benefiting from its shift toward smoke-free products. This, along with pricing power, is aiding PM amid currency headwinds.
Time to Buy These Big Tobacco Stocks for Higher Highs?
by Shaun Pruitt
Big tobacco producers Altria Group (MO) and Philip Morris International (PM) have seen their stocks soar over +30% this year with both trading near 52-week highs.
3 Reasons Growth Investors Will Love Philip Morris (PM)
by Zacks Equity Research
Philip Morris (PM) could produce exceptional returns because of its solid growth attributes.
Altria (MO) Up 6.7% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Altria (MO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Altria Rallies 15% in 3 Months: Should You Buy, Hold or Sell MO Stock?
by Vrishali Bagree
Altria's push into smoke-free products presents promising growth opportunities, but the ongoing decline in its cigarette business poses challenges for MO stock.
Zacks Investment Ideas feature highlights: DaVita, Starwood Property and Philip Morris
by Zacks Equity Research
DaVita, Starwood Property and Philip Morris have been highlighted in this Investment Ideas article.
3 Defensive Stocks Outperforming in a Choppy Market (PM, DVA, STWD)
by Ethan Feller
Philip Morris International, Starwood Property Trust and DaVita all show relative strength and top Zacks Ranks
Are Consumer Staples Stocks Lagging Carriage Services (CSV) This Year?
by Zacks Equity Research
Here is how Carriage Services (CSV) and Philip Morris (PM) have performed compared to their sector so far this year.
Why Philip Morris (PM) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here is Why Growth Investors Should Buy Philip Morris (PM) Now
by Zacks Equity Research
Philip Morris (PM) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Nu Skin (NUS) Trims FY24 View Despite Q2 Earnings Beat
by Zacks Equity Research
Nu Skin's (NUS) second-quarter 2024 results reflect lower earnings and net sales amid a dynamic macro-environment. Management lowers the 2024 guidance range.
Is Carriage Services (CSV) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how Carriage Services (CSV) and Philip Morris (PM) have performed compared to their sector so far this year.
Inter Parfums (IPAR) Q2 Earnings Top, Sales Up on Robust Demand
by Zacks Equity Research
Inter Parfums' (IPAR) second-quarter 2024 results reflect higher sales and earnings on continued momentum in the fragrance market and strength in its legacy and new brands.
B&G Foods (BGS) Q2 Earnings Meet Estimates, Unit Volumes Dip
by Zacks Equity Research
B&G Foods' (BGS) second-quarter 2024 results reflect lower earnings and sales amid demand challenges in the consumer-packaged food space.
TreeHouse Foods (THS) Q2 Earnings Beat Estimates, Sales Drop
by Zacks Equity Research
TreeHouse Foods' (THS) Q2 results reflect declines in sales and earnings on lower volumes. Management lowers the upper end of its adjusted EBITDA guidance for 2024.
4 Consumer Staples Stocks to Buy Amid Wall Street Bloodbath
by Ritujay Ghosh
Consumer staple stocks like Colgate-Palmolive Company (CL), Kimberly-Clark Corporation (KMB), The Coca-Cola Company (KO) and Philip Morris International Inc. (PM) are a safe bet during times of market volatility.
Tyson Foods (TSN) Q3 Earnings & Sales Top Estimates, Up Y/Y
by Zacks Equity Research
Tyson Foods' (TSN) Q3 results reflect increased sales and earnings on continued operational momentum. Management raises the lower end of its adjusted operating income guidance range for fiscal 2024.